Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Syneos Health Shares Jump On Better Than Expected Q1 Earnings, FY22 Outlook

  • Syneos Health Inc's (NASDAQ:SYNHQ1 revenue increased 10.5% on a reported basis and 11.7% on a constant currency (CC) basis to $1.34 billion, beating the consensus of $1.32 billion.
  • Clinical Solutions revenue increased 8.4% (+9.6% CC) to $1.02 billion. Acquisitions contributed approximately 1,00 basis points to Clinical Solutions' reported revenue growth. 
  • Commercial Solutions revenue increased 18.1% (+18.9% CC) to $317.9 million.
  • Adjusted EBITDA of $173.6 million increased 14.9% Y/Y.
  • The Company posted an adjusted EPS of $1.01, +27.8% Y/Y, beating the consensus of $0.95.
  • Net new business awards (Excluding reimbursable out-of-pocket expenses) reached 1.24 billion.
  • Management Change: Syneos Health appointed Michelle Keefe as CEO and a board member.
  • Keefe, currently President, Medical Affairs and Commercial Solutions, succeeds Alistair Macdonald, who will retire after 20 years at Syneos Health.
  • Guidance: Syneos projects FYY22 sales of $5.6 billion - $5.75 billion, unchanged from previous guidance, compared to the consensus of $5.65 billion.
  • The Company raised EPS guidance to $5.05 -$5.25, up from the prior outlook of $4.98 - $5.24 vs. the $5.08 consensus.
  • Syneos Health expects an adjusted EBITDA of $845 million - $885 million compared to the prior outlook of $840 million - $880 million.
  • Price Action: SYNH shares are up 4.80% at $73.84 during the market session on the last check Friday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.